Skip to main content

IRB Committee 2

IRB Committee 2 is responsible for the full review of human subjects research protocols for the C.T. Bauer School of Business, the College of the Arts, and the College of Liberal Arts and Social Sciences (CLASS), with the exception of the Department of Health and Human Performance. IRB 2 does not review FDA-regulated research. 

Full Committee

Submission Deadlines Meeting Dates*
Friday, September 9, 2016 Friday, September 23, 2016
Friday, October 14, 2016 Friday, October 28, 2016
Friday, November 4, 2016 Friday, November 18, 2016
Friday, November 23, 2016 Friday, December 9, 2016
Friday, January 13, 2017 Friday, January 27, 2017
Friday, February 10, 2017 Friday, February 24, 2017
Friday, March 10, 2017 Friday, March 24, 2017
Friday, April 14, 2017 Friday, April 28, 2017
Friday, May 12, 2017 Friday, May 26, 2017
Friday, June 9, 2017 Friday, June 23, 2017
Friday, July 14, 2017 Friday, July 28, 2017
Friday, August 11, 2017 Friday, August 25, 2017

*Dates are subject to change without notice if circumstances require rescheduling.

Expedited Review

Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 2 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approves or requires modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.  

Exempt Status

Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.